These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11741774)

  • 1. Kinetic and crystallographic studies of glucopyranosylidene spirothiohydantoin binding to glycogen phosphorylase B.
    Oikonomakos NG; Skamnaki VT; Osz E; Szilágyi L; Somsák L; Docsa T; Tóth B; Gergely P
    Bioorg Med Chem; 2002 Feb; 10(2):261-8. PubMed ID: 11741774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucopyranosylidene-spiro-iminothiazolidinone, a new bicyclic ring system: synthesis, derivatization, and evaluation for inhibition of glycogen phosphorylase by enzyme kinetic and crystallographic methods.
    Czifrák K; Páhi A; Deák S; Kiss-Szikszai A; Kövér KE; Docsa T; Gergely P; Alexacou KM; Papakonstantinou M; Leonidas DD; Zographos SE; Chrysina ED; Somsák L
    Bioorg Med Chem; 2014 Aug; 22(15):4028-41. PubMed ID: 25009003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex.
    Kosmopoulou MN; Leonidas DD; Chrysina ED; Bischler N; Eisenbrand G; Sakarellos CE; Pauptit R; Oikonomakos NG
    Eur J Biochem; 2004 Jun; 271(11):2280-90. PubMed ID: 15153119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
    Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
    Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of beta- and gamma-cyclodextrins to glycogen phosphorylase b: kinetic and crystallographic studies.
    Pinotsis N; Leonidas DD; Chrysina ED; Oikonomakos NG; Mavridis IM
    Protein Sci; 2003 Sep; 12(9):1914-24. PubMed ID: 12930991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.
    Oikonomakos NG; Kosmopoulou M; Zographos SE; Leonidas DD; Chrysina ED; Somsák L; Nagy V; Praly JP; Docsa T; Tóth B; Gergely P
    Eur J Biochem; 2002 Mar; 269(6):1684-96. PubMed ID: 11895439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
    Alexacou KM; Tenchiu Deleanu AC; Chrysina ED; Charavgi MD; Kostas ID; Zographos SE; Oikonomakos NG; Leonidas DD
    Bioorg Med Chem; 2010 Nov; 18(22):7911-22. PubMed ID: 20947361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
    Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H
    Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
    Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
    Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
    Mitchell EP; Withers SG; Ermert P; Vasella AT; Garman EF; Oikonomakos NG; Johnson LN
    Biochemistry; 1996 Jun; 35(23):7341-55. PubMed ID: 8652510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding.
    Gregoriou M; Noble ME; Watson KA; Garman EF; Krulle TM; de la Fuente C; Fleet GW; Oikonomakos NG; Johnson LN
    Protein Sci; 1998 Apr; 7(4):915-27. PubMed ID: 9568898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
    Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
    Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs.
    Oikonomakos NG; Kosmopoulou MN; Chrysina ED; Leonidas DD; Kostas ID; Wendt KU; Klabunde T; Defossa E
    Protein Sci; 2005 Jul; 14(7):1760-71. PubMed ID: 15987904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new allosteric site in glycogen phosphorylase b as a target for drug interactions.
    Oikonomakos NG; Skamnaki VT; Tsitsanou KE; Gavalas NG; Johnson LN
    Structure; 2000 Jun; 8(6):575-84. PubMed ID: 10873856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1.76 A resolution crystal structure of glycogen phosphorylase B complexed with glucose, and CP320626, a potential antidiabetic drug.
    Oikonomakos NG; Zographos SE; Skamnaki VT; Archontis G
    Bioorg Med Chem; 2002 May; 10(5):1313-9. PubMed ID: 11886794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site.
    Chrysina ED; Kosmopoulou MN; Tiraidis C; Kardakaris R; Bischler N; Leonidas DD; Hadady Z; Somsak L; Docsa T; Gergely P; Oikonomakos NG
    Protein Sci; 2005 Apr; 14(4):873-88. PubMed ID: 15741340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP.
    Barford D; Hu SH; Johnson LN
    J Mol Biol; 1991 Mar; 218(1):233-60. PubMed ID: 1900534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the reversible enzyme reaction of rabbit muscle glycogen phosphorylase b using isothermal titration calorimetry.
    Szabó K; Kandra L; Gyémánt G
    Carbohydr Res; 2019 May; 477():58-65. PubMed ID: 31005807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
    Watson KA; Mitchell EP; Johnson LN; Cruciani G; Son JC; Bichard CJ; Fleet GW; Oikonomakos NG; Kontou M; Zographos SE
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):458-72. PubMed ID: 15299833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallographic studies on two bioisosteric analogues, N-acetyl-beta-D-glucopyranosylamine and N-trifluoroacetyl-beta-D-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase.
    Anagnostou E; Kosmopoulou MN; Chrysina ED; Leonidas DD; Hadjiloi T; Tiraidis C; Zographos SE; Györgydeák Z; Somsák L; Docsa T; Gergely P; Kolisis FN; Oikonomakos NG
    Bioorg Med Chem; 2006 Jan; 14(1):181-9. PubMed ID: 16213146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.